# Prevention Trial of Nosocomial Infections in Neutropenic Prematures With G-CSF

> **NCT00213759** · PHASE3 · COMPLETED · sponsor: **University Hospital, Strasbourg, France** · enrollment: 200 (actual)

## Conditions studied

- Neutropenia in Prematures

## Interventions

- **DRUG:** filgrastim
- **DRUG:** dextrose 5%

## Key facts

- **NCT ID:** NCT00213759
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** —
- **Final completion:** 2006-08
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2007-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00213759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00213759, "Prevention Trial of Nosocomial Infections in Neutropenic Prematures With G-CSF". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00213759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*